ENADENOTUCIREV
UNII KX7ZYR6OQW

Substance Identification & Data

This profile provides standardized clinical and technical data for Enadenotucirev, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KX7ZYR6OQW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1402042-02-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KX7ZYR6OQW
CAS Registry Number
1402042-02-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ENADENOTUCIREV
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C113786
National Cancer Institute reference terminology for clinical and research data.
INN ID
9887
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enadenotucirev. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENADENOTUCIREV

Common Names & Synonyms

CHIMERIC ONCOLYTIC ADENOVIRUS AD3/AD11P CONTAINING TWO DELETIONS IN THE VIRAL GENOME IN THE E3 REGION (2444 BP) AND IN THE E4 REGION (24 BP) AND 197 NON-HOMOLOGOUS NUCLEOTIDES IN THE E2B REGION
ENADENOTUCIREV [INN]
ENADENOTUCIREV [WHO-DD]
ONCOLYTIC A11/AD3 CHIMERIC GROUP B ADENOVIRUS

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus